Skip to main content
Published locations for Benefits of gemtuzumab ozogamicin outweigh risks, ODAC says
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Benefits of gemtuzumab ozogamicin outweigh risks, ODAC says
User login
Username
Password
Reset your password
/content/benefits-gemtuzumab-ozogamicin-outweigh-risks-odac-says
/hematology-oncology/article/185568/leukemia-myelodysplasia-transplantation/benefits-gemtuzumab-ozogamicin
/hematologytimes/article/185568/leukemia-myelodysplasia-transplantation/benefits-gemtuzumab